Immunocore
company
Funding Round
Post-IPO Equity
Money Raised
$ 140M
Propotion
-
Post Valuation
-
Current Round Investors
| Investor Name | Invest Money | Lead Investor | Propotion | |
|---|---|---|---|---|
| General Atlantic | - | - | - | Detail |
| Rock Springs Capital | - | - | - | Detail |
| RTW Investments | - | - | - | Detail |
Historical Financing
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| Jan 11, 2021 | Series C | $ 75M | BlackRock | Detail |
| Jul 16, 2015 | Series A | $ 320M | Eli Lilly,RTW Investments,etc. | Detail |
| Nov 5, 2012 | Grant | £ 2.40M | Biomedical Catalyst Fund | Detail |
| Jan 11, 2021 | Debt Financing | $ 100M | Oxford Finance LLC | Detail |
| Mar 2, 2020 | Series B | $ 130M | Bill & Melinda Gates Foundation,CCB International,etc. | Detail |
| Sep 18, 2017 | Series B | $ 40M | Bill & Melinda Gates Foundation | Detail |
| Feb 4, 2021 | IPO | $ 258.31M | Detail |
